Araştırma Makalesi

Beliefs and experiences of breast cancer patients about the use of complementary therapies: A qualitative study

Cilt: 45 Sayı: 2 30 Haziran 2020
PDF İndir
EN TR

Beliefs and experiences of breast cancer patients about the use of complementary therapies: A qualitative study

Abstract

Purpose: Breast cancer patients prefer to use complementary therapies (CT) along with medical treatment to improve their health. However, patients don’t share detailed information regarding the use of CT with healthcare professionals. The aim of this study is to examine the beliefs and experiences of breast cancer patients receiving chemotherapy regarding the use of CT.
Materials and Methods: Individual interviews were conducted with 11 breast cancer patients through a semi-structured interview form in June-July 2019. Six-phase thematic analysis was used to analyze the data.
Results: Three main themes were identified in the study: Types of CT used, CT preferences, and positive experiences. In terms of CT types, patients use natural products, and mind and body practices. Patients prefer these methods to prevent the progression of the disease, not to use medical drugs, reduce the side effects of the treatment, or because they don’t believe in the therapeutic effect of chemotherapy. Physiological recovery and immunity enhancement are among the positive experiences after the use of CT. Patients continue to use these methods because they have positive experiences related to the use of CT.
Conclusion: Breast cancer patients mostly prefer natural products followed by mind and body practices. Patients receive very little guidance from healthcare professionals regarding the use of CT and prefer to use social communication resources for such information. Advices given by oncology physicians and nurses to the patients in the light of the current evidence-based literature whether to continue using CT are crucial for the health of the patient.

Keywords

Breast cancer,complementary therapies

Kaynakça

  1. 1. WHO. Cancer Today Data visualization tools for exploring the global cancer burden in 2018. http://gco.iarc.fr/today/home (accessed January 15, 2020).
  2. 2. Bellanger M, Zeinomar N, Tehranifar P, Terry MB. Are global breast cancer incidence and mortality patterns related to country-specific economic development and prevention strategies? J Glob Oncol. 2018;(4):1-16.
  3. 3. T.C. Sağlık Bakanlığı. Kanser tedavileri nelerdir. https://hsgm.saglik.gov.tr/tr/kanser-tedavisi (accessed January 15, 2020).
  4. 4. Oylar Ö, Tekin İ. Kanserin teşhis ve tedavisinde nanoteknolojinin önemi. Uludağ Üniversitesi Mühendislik-Mimarlık Fakültesi Dergisi. 2011;16(1):147-54.
  5. 5. NCCIH. Complementary, alternative, or integrative health: what’s in a name? https://nccih.nih.gov/health/integrative-health#hed1 (accessed May 13, 2019).
  6. 6. European Federation for Complementary and Alternative Medicine [EFCAM]. CAM definition. http://www.efcam.eu/cam/cam-definition/ (accessed July 18, 2019).
  7. 7. Chui PL, Abdullah KL, Wong LP, Taib NA. Complementary and alternative medicine use and symptom burden in women undergoing chemotherapy for breast cancer in Malaysia. Cancer Nurs. 2018;41(3):189-99.
  8. 8. Yeşil H, Kiran B, Alkan H, Ateş B, Kayali B, Büyükçam S, et al. Afyon Kocatepe Üniversitesi’nde meme kanseri tanısı ile takip edilmekte olan hastalarda tamamlayıcı ve alternatif tedavi kullanımı. Kocatepe Medical Journal. 2018;19:42-7.
  9. 9. Kurt H, Keşkek ŞÖ, Çil T, Canataroğlu A. Meme kanserli hastalarda tamamlayıcı/ alternatif tedavi kullanımı. Turkish Journal of Oncology. 2013;28(1):10-5.
  10. 10. Hwang JH, Kim WY, Ahmed M, Choi S, Kim J, Han DW. The use of complementary and alternative medicine by Korean breast cancer women: is it associated with severity of symptoms? Evidence-based Complement Altern Med. 2015;2015:1-7.

Kaynak Göster

MLA
Tuzcu, Ayla, ve Merve İpek. “Beliefs and experiences of breast cancer patients about the use of complementary therapies: A qualitative study”. Cukurova Medical Journal, c. 45, sy 2, Haziran 2020, ss. 629-38, doi:10.17826/cumj.699833.